Brief: Phathom Pharmaceuticals Submits Citizen Petition To FDA
Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O :
* PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA
SEEKING
CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN)
TABLETS
* PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK
LISTINGS
FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR
NCE EXCLUSIVITY PERIOD
* PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL
MAY 3,
2032
Source text: ID:nGNXMt0NF
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates